My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Información en Ciencias de la Salud
On-line version ISSN 2307-2113
Abstract
DIAZ PEREZ, Maidelyn et al. Tuberculosis, Bacillus Calmette-Guérin (BCG) and tuberculosis vaccines: a patent analysis. Rev. cuba. inf. cienc. salud [online]. 2014, vol.25, n.3, pp. 259-269. ISSN 2307-2113.
As an object of study, the relationship between tuberculosis, Bacillus Calmette-Guérin and tuberculosis vaccines starts from the fact that the only vaccine currently available to prevent tuberculosis in humans is BCG, and its improvement or the development of new vaccines is a key strategy to control the disease. The present study intends to make a contribution to such important research from a patent metrics perspective. Its purpose is to conduct a metric analysis allowing to describe the productivity of patents for tuberculosis, Bacillus Calmette-Guérin and tuberculosis vaccines in a given time period. For the productivity study, an analysis was carried out of the behavior of temporal and geographic indicators in the domain, using techniques and tools suitable for patent documents. Research into tuberculosis as an infectious communicable disease has received great attention. Until recently, tuberculosis was considered to be a health problem in the developing world. However, after its re-emergence, research has been mainly conducted in developed countries. But such efforts have not been in proportion to research aimed at developing a new generation of vaccines against the disease, and there are no new patents supporting them.
Keywords : tuberculosis (TB); Bacillus Calmette-Guérin (BCG); tuberculosis vaccines; metric studies; patents; scientific and technological productivity.